HCID 21273890, compound → HCID 69795946, compound
Reaction equation
[Br:1][CH2:2][CH2:3][CH2:4][CH:5]([N:31]1[C:35](=[O:36])[C:34]2=[CH:37][CH:38]=[CH:39][CH:40]=[C:33]2[C:32]1=[O:41])[C:6]([N:8]1[C:13]([C:14]([O:16][C:17]([CH3:20])([CH3:19])[CH3:18])=[O:15])=[CH:12][CH:11]=[CH:10][N:9]1C(OCC1C=CC=CC=1)=O)=[O:7].[H][H]>C(O)C.[Pd]>[Br:1][CH2:2][CH2:3][CH2:4][CH:5]([N:31]1[C:35](=[O:36])[C:34]2=[CH:37][CH:38]=[CH:39][CH:40]=[C:33]2[C:32]1=[O:41])[C:6]([N:8]1[C:13]([C:14]([O:16][C:17]([CH3:20])([CH3:19])[CH3:18])=[O:15])=[CH:12][CH:11]=[CH:10][NH:9]1)=[O:7]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
2.37 g of 1-benzyl 3-tert.butyl 2-(5-bromo-2-phthalimidovaleryl)-1,3-pyridazinedicarboxylate (2 diastereomers) were dissolved in 25 ml of ethanol and the solution was hydrogenated at atmospheric pressure over 50 mg of 10% palladium-on-carbon until the uptake of hydrogen had ceased. The catalyst was removed by filtration and the filtrate was evaporated to give 1.79 g (96%) of tert.butyl 2-(5-bromo-2-phthalimidovaleryl)-3-pyridazinecarboxylate (2 diastereomers) in the form of an oil.
Workup
- customThe catalyst was removed by filtration
- customthe filtrate was evaporated
Sources & evidence
- ORD record
- ord-7c458184d08f40a5a3364a1b245f7515
- Source dataset
- uspto-grants-1987_04
- Patent number
- US04658024
Reaction notes
Loading…